Femur

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients: 94 percent (291) of patients had taken the drugs, most for more than five years

By on

2010 study posted for filing Contact: Sara Knoll sknoll@burnesscommunications.com 301-652-1558 Burness Communications Expert panel calls for additional product labeling, international patient registry Washington, DC, SEPTEMBER 14, 2010– A widely prescribed class of drugs is highly effective in reducing common bone… Read More ›